Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

被引:8
|
作者
Kelepouris, Ellie [1 ]
St. Peter, Wendy [2 ,3 ]
Neumiller, Joshua J. [4 ]
Wright, Eugene E. [5 ]
机构
[1] Univ Penn, Div Renal Electrolyte & Hypertens, Philadelphia, PA 19104 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Hennepin Healthcare Res Inst, Minneapolis, MN USA
[4] Washington State Univ, Spokane, WA USA
[5] Charlotte Area Hlth Educ Ctr, Charlotte, NC USA
关键词
Chronic kidney disease; Type 2 diabetes mellitus; Multidisciplinary care; Multidisciplinary team; Care optimization; Prevention; CARDIOVASCULAR OUTCOMES; PHARMACIST INTERVENTION; MEDICATION ADHERENCE; THERAPY MANAGEMENT; NEPHROPATHY; NEPHROLOGY; MORTALITY; CKD; HOSPITALIZATION; FINERENONE;
D O I
10.1007/s13300-023-01416-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriate therapeutic interventions that slow disease progression and prevent adverse outcomes. Due to the complex nature of diabetes and CKD management, a holistic, patient-centered, collaborative care approach delivered by a coordinated multidisciplinary team (ideally including a clinical pharmacist as part of a comprehensive medication management program) is needed. In this review, we discuss the barriers to effective care, the current multidisciplinary approach used for CKD prevention and treatment, and the potential ways that the multidisciplinary management of CKD associated with type 2 diabetes mellitus can be refined to improve patient outcomes.
引用
收藏
页码:1111 / 1136
页数:26
相关论文
共 50 条
  • [31] Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
    Hsu, Wei-Hao
    Hsiao, Pi-Jung
    Lin, Pi-Chen
    Chen, Szu-Chia
    Lee, Mei-Yueh
    Shin, Shyi-Jang
    ONCOTARGET, 2018, 9 (04) : 5416 - 5423
  • [32] Multidisciplinary care for poor patients with chronic kidney disease in Mexico
    Garcia-Garcia, Guillermo
    Martinez-Castellanos, Yolanda
    Renoirte-Lopez, Karina
    Barajas-Murguia, Alberto
    de la Torre-Campos, Librado
    Becerra-Munoz, Laura E.
    Gonzalez-Alvarez, Jaime A.
    Tonelli, Marcello
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (02) : 178 - 183
  • [33] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [34] Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
    Berezina, Tetiana A.
    Obradovic, Zeljko
    Boxhammer, Elke
    Berezin, Alexander A. A.
    Lichtenauer, Michael
    Berezin, Alexander E. E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [35] Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus
    Low, Serena K. M.
    Sum, Chee Fang
    Yeoh, Lee Ying
    Tavintharan, Subramaniam
    Ng, Xiao Wei
    Lee, Simon B. M.
    Tang, Wern Ee
    Lim, Su Chi
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (05) : 164 - 171
  • [36] Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
    Lawson, Claire A.
    Seidu, Samuel
    Zaccardi, Francesco
    McCann, Gerry
    Kadam, Umesh T.
    Davies, Melanie J.
    Lam, Carolyn S. P.
    Heerspink, Hiddo L.
    Khunti, Kamlesh
    ECLINICALMEDICINE, 2021, 32
  • [37] Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone
    Ortiz, Alberto
    Arroyo, Roberto Alcazar
    Escribano, Pedro Pablo Casado
    Fernandez-Fernandez, Beatriz
    Deben, Francisco Martinez
    Mediavilla, Juan Diego
    Michan-Dona, Alfredo
    Soler, Maria Jose
    Gorriz, Jose Luis
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (06) : 519 - 531
  • [38] Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: A longitudinal study in Taiwan
    Chung, Hsin-Fang
    Al Mamun, Abdullah
    Huang, Meng-Chuan
    Long, Kurt Z.
    Huang, Ya-Fang
    Shin, Shyi-Jang
    Hwang, Shang-Jyh
    Hsu, Chih-Cheng
    JOURNAL OF DIABETES, 2017, 9 (11) : 983 - 993
  • [39] Time to develop chronic kidney disease in an Ecuadorian Type 2 Diabetes Mellitus cohort: Survival analysis in primary care
    Carrasco-Tenezaca, Felipe
    Barrera-Guarderas, Francisco
    De la Torre-Cisneros, Katherine
    Medina-Escudero, Miguel
    Venegas-Baca, Oscar
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (02)
  • [40] High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function
    Kim, Won Jin
    Kim, Sang Soo
    Bae, Min Jung
    Yi, Yang Seon
    Jeon, Yun Kyung
    Kim, Bo Hyun
    Song, Sang Heon
    Kim, In Joo
    Kim, Yong Ki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (02) : 130 - 134